Key Deal Facts
Over $12 million booked revenue from 20 pharmaceutical and biotech companies
Founded by cancer survivors and caregivers
Established patient community with 50 million interactions to date
$5 million in projected sales pipeline with 23 treatment development clients
$13.4 billion annual TAM across patient insights, clinical trial recruiting, & treatment marketing
New FDA requirements make Gryt's services critical
$5.5 million invested from 18 investors and 4 funds, including The Omidyar Group (founder of eBay)
Team of industry experts from pharma, Wall Street, tech, research, and patient advocacy
Management Team / Advisory Board Bios
$1M+ Revenue
Earned over the last 12 months, David Craig Board Member & CEO2x Testicular Cancer Survivor, Patient Experience Researcher and Pharma Executive, Shelley NoldenBoard Chair & Angel InvestorLeukemia Survivor, Founding Member of a Wall Street Firm, Brad LoveBoard Member & Chief Culture OfficerAssociate Director, Center for Health Communication, University of Texas, Bill WalshChief Financial OfficerCancer Survivor, Former General Motors Financial Analyst, Uma RanaChief of Strategic PartnershipsPharma Executive in Digital Health, Transformation & Strategy, David AleksandrowiczChief Information OfficerCancer Caregiver, Entrepreneur and Software Developer, Sheila ThorneBoard MemberExpertise in designing and implementing multicultural marketing campaigns for the pharmaceutical, biotech and medical device industry, Guy Boike, MDBoard MemberDr. Boike has over 40 years of experience in gynecological cancer treatment and has been published in many peer-reviewed publications and research studies., Gryt Staff Staff